3 Lucky Players Share $180,000 in the9bits August Fiesta Finale
Singapore, Sept. 05, 2025 (GLOBE NEWSWIRE) -- the9bit, an innovative gaming platform…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented…
Ram Rattan Group Launches The Green Step Farms Phase 2 & Aravalli Retreat in Ram Rattan’s Naugaon
NEW DELHI, Aug. 23, 2025 /PRNewswire/ -- Ram Rattan Group has launched…
First Phase of IIPD Kasaragod, a Model Project to Empower Individuals with Disabilities, to be Completed in 2026, Fully Operational by 2029
THIRUVANANTHAPURAM, India, Aug. 18, 2025 /PRNewswire/ -- The first phase of the…
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
August 21, 2025 01:30 ET | Source: NICOX SA Press Release Nicox…
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE…
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer…
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC…
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…